Welcome to Mitrade

Almost nothing can stop ‘risk’ FX – GBP, AUD, EUR and NZD are finishing the year in incredibly strong up channels.

The GBP is the most interesting here considering the probability of a Brexit Free Trade Agreement (FTA) with the EU is, in the words of Prime Minster Boris Johnson, ‘below 20%’. As of Monday, the GBP is now in a net long scenario as seen here.

What is also interesting as we finish 2020 is the USD’s downward trajectory remains unabated. In fact, it’s actually accelerating as the forecasted stimulus hopes of Biden Administration and a Federal Reserve that is posed to do more start to become fact.

US House Speaker Nancy Pelosi and Treasury Secretary Steve Mnuchin are inching closer to their COVID relief bill. The market is becoming more confident the bill will pass now that Senate leader Mitch McConnell, Senate Democratic Leader Larry Schumer and House Minority Leader Kevin McCarthy formed a bipartisan group and released a proposal for $748bn aid package excluding the two most contentious and partisan issues. This bill is seen as a ‘bridging’ proposal before a large and more board agreement is created under the new administration.

This proposed stimulus support is a huge USD negative as no other G10 currency can compete with the sheer size of the packages being put forward. This has seen G10 pairs explode higher with the GBP/USD up to $1.3445, a break above $1.349 would be a new yearly high for 2020. EUR/USD at $1.2168 continues to show that even in the face of COVID crisis across the Atlantic, risk sees 2021 in a positive light. This position was enhanced by the FDA announcing that the Moderna’s COVID vaccine is safe and effective in people ages 18 and older, clearing the way for emergency authorisation the same as the Pfizer vaccine.

Finally, there is the AUD/USD which is continuing to chase new 2 ½ year highs as export prices reach 7-year highs and the RBA holds the line on new packages. At $0.7572 there is every chance the pair would test the level of $0.76 and would put the medium-term resistance at $0.79.

This information has been prepared by Mitrade. In addition to the disclaimer below, Mitrade does not represent that the information provided here is accurate, current or complete, and therefore should not be relied upon as such. This information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Mitrade is not a financial advisor and all services are provided on an execution only basis. We advise any readers of this content to seek their own advice. Reproduction or redistribution of this information is not permitted.

Derivatives trading involves risks and the above information is not suitable for everyone. Refer to our PDS and ensure you understand the risks involved.